Reborna Biosciences, Inc.

Reborna Biosciences, Inc. is dedicated to saving the lives of rare disease patients and supporting their families through innovative RNA binding molecules. Based in Fujisawa, Kanagawa, Reborna Biosciences is at the forefront of biotechnology research, focusing on the development of RNA-targeting small molecule drugs for rare genetic diseases. Their proprietary screening method identifies orally available small molecules by replicating the natural three-dimensional structure of RNA found in the human body, potentially leading to drug candidates with enhanced clinical efficacy and fewer side effects.

Reborna Biosciences is committed to advancing therapeutic solutions with higher efficacy and fewer side effects. Located at 2-26-1, Muraoka-Higashi, Fujisawa, Kanagawa 251-8555, JP, Reborna Biosciences aims to make a significant impact on the treatment of rare genetic diseases through groundbreaking research and development.

Reborna Biosciences is poised to revolutionize the biotechnology sector with its unique approach to drug discovery. We invite the management of Reborna Biosciences to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative work.